OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
April 13, 2010
The faces and names behind the year's best pharmaceutical advertising.
March 01, 2010
Merckâ€™s Man in Emerging Markets
From the Editor
Is it possible to remain commercially relevant just as a developer and distributor of drugs? Are there equivalent profits in a larger set of commitments?
Pricing, promotion, and the unfinished story of healthcare reform dominated the news last year.
In a digital world, vast quantities of data at hand are a powerful asset. Managing that information is key to seizing competitive advantage.
FDA's new Sentinel System is going live, but the signals may be difficult to assess.
Several leading pharmas may already have a drug for a retrovirus linked to chronic fatigue disease. Has medicine's "problem child" finally earned the industry's respect?
Pharma companies need a clear online policy that addresses employee obligations, monitoring guidelines, and engagement roles.
Obligations to fund and support costly studies can extend beyond the period of market exclusivity, giving generics competitors an advantage.
Here are five pharmaceutical advertisement parodies that will make you howl 'till it hurts.
Can the combination with Schering-Plough transform the company from an also-ran to a contender in the big push for market share in the developing world?